These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 30726894)

  • 1. Ciclosporin Therapy After Infliximab Failure in Hospitalized Patients With Acute Severe Colitis is Effective and Safe.
    Weisshof R; Ollech JE; El Jurdi K; Yvellez OV; Cohen RD; Sakuraba A; Dalal S; Pekow J; Rubin DT
    J Crohns Colitis; 2019 Sep; 13(9):1105-1110. PubMed ID: 30726894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study).
    García MJ; Riestra S; Amiot A; Julsgaard M; García de la Filia I; Calafat M; Aguas M; de la Peña L; Roig C; Caballol B; Casanova MJ; Farkas K; Boysen T; Bujanda L; Cuarán C; Dobru D; Fousekis F; Gargallo-Puyuelo CJ; Savarino E; Calvet X; Huguet JM; Kupcinskas L; López-Cardona J; Raine T; van Oostrom J; Gisbert JP; Chaparro M
    Aliment Pharmacol Ther; 2024 May; 59(10):1248-1259. PubMed ID: 38445785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab.
    Laharie D; Bourreille A; Branche J; Allez M; Bouhnik Y; Filippi J; Zerbib F; Savoye G; Vuitton L; Moreau J; Amiot A; Cosnes J; Ricart E; Dewit O; Lopez-Sanroman A; Fumery M; Carbonnel F; Bommelaer G; Coffin B; Roblin X; van Assche G; Esteve M; Farkkila M; Gisbert JP; Marteau P; Nahon S; de Vos M; Lambert J; Mary JY; Louis E;
    Gut; 2018 Feb; 67(2):237-243. PubMed ID: 28053054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximab.
    Croft A; Walsh A; Doecke J; Cooley R; Howlett M; Radford-Smith G
    Aliment Pharmacol Ther; 2013 Aug; 38(3):294-302. PubMed ID: 23786158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.
    Laharie D; Bourreille A; Branche J; Allez M; Bouhnik Y; Filippi J; Zerbib F; Savoye G; Nachury M; Moreau J; Delchier JC; Cosnes J; Ricart E; Dewit O; Lopez-Sanroman A; Dupas JL; Carbonnel F; Bommelaer G; Coffin B; Roblin X; Van Assche G; Esteve M; Färkkilä M; Gisbert JP; Marteau P; Nahon S; de Vos M; Franchimont D; Mary JY; Colombel JF; Lémann M;
    Lancet; 2012 Dec; 380(9857):1909-15. PubMed ID: 23063316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ciclosporin or Infliximab as Rescue Therapy in Acute Glucorticosteroid-Refractory Ulcerative Colitis: Systematic Review and Network Meta-Analysis.
    Barberio B; Black CJ; Savarino EV; Ford AC
    J Crohns Colitis; 2021 May; 15(5):733-741. PubMed ID: 33175102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients.
    Protic M; Seibold F; Schoepfer A; Radojicic Z; Juillerat P; Bojic D; Mwinyi J; Mottet C; Jojic N; Beglinger C; Vavricka S; Rogler G; Frei P
    J Crohns Colitis; 2014 Nov; 8(11):1427-37. PubMed ID: 24908178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial.
    Williams JG; Alam MF; Alrubaiy L; Arnott I; Clement C; Cohen D; Gordon JN; Hawthorne AB; Hilton M; Hutchings HA; Jawhari AU; Longo M; Mansfield J; Morgan JM; Rapport F; Seagrove AC; Sebastian S; Shaw I; Travis SP; Watkins A
    Lancet Gastroenterol Hepatol; 2016 Sep; 1(1):15-24. PubMed ID: 27595142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised controlled trial. Comparison Of iNfliximab and ciclosporin in STeroid Resistant Ulcerative Colitis: Trial design and protocol (CONSTRUCT).
    Seagrove AC; Alam MF; Alrubaiy L; Cheung WY; Clement C; Cohen D; Grey M; Hilton M; Hutchings H; Morgan J; Rapport F; Roberts SE; Russell D; Russell I; Thomas L; Thorne K; Watkins A; Williams JG
    BMJ Open; 2014 Apr; 4(4):e005091. PubMed ID: 24785401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison Of iNfliximab and ciclosporin in STeroid Resistant Ulcerative Colitis: pragmatic randomised Trial and economic evaluation (CONSTRUCT).
    Williams JG; Alam MF; Alrubaiy L; Clement C; Cohen D; Grey M; Hilton M; Hutchings HA; Longo M; Morgan JM; Rapport FL; Seagrove AC; Watkins A
    Health Technol Assess; 2016 Jun; 20(44):1-320. PubMed ID: 27329657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study.
    Chaparro M; Burgueño P; Iglesias E; Panés J; Muñoz F; Bastida G; Castro L; Jiménez C; Mendoza JL; Barreiro-de Acosta M; Senent SG; Gomollón F; Calvet X; García-Planella E; Gómez M; Hernández V; Hinojosa J; Mañosa M; Nyssen OP; Gisbert JP
    Aliment Pharmacol Ther; 2012 Jan; 35(2):275-83. PubMed ID: 22142227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the ulcerative colitis endoscopic index of severity (UCEIS) and outcomes in acute severe ulcerative colitis.
    Corte C; Fernandopulle N; Catuneanu AM; Burger D; Cesarini M; White L; Keshav S; Travis S
    J Crohns Colitis; 2015 May; 9(5):376-81. PubMed ID: 25770163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colectomy rates in patients with ulcerative colitis following treatment with infliximab or ciclosporin: a systematic literature review.
    Thorne K; Alrubaiy L; Akbari A; Samuel DG; Morrison-Rees S; Roberts SE
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):369-82. PubMed ID: 26825217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab versus cyclosporine for severe ulcerative colitis refractory to steroids: A protocol for systematic review and meta-analysis.
    Wu D; Yang Z; Zhao C; Yao L
    Medicine (Baltimore); 2018 Oct; 97(41):e12657. PubMed ID: 30313056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rescue therapy with cyclosporine or infliximab is not associated with an increased risk for postoperative complications in patients hospitalized for severe steroid-refractory ulcerative colitis.
    Nelson R; Liao C; Fichera A; Rubin DT; Pekow J
    Inflamm Bowel Dis; 2014 Jan; 20(1):14-20. PubMed ID: 24297054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved outcome of acute severe ulcerative colitis while using early predictors of corticosteroid failure and rescue therapies.
    Llaó J; Naves JE; Ruiz-Cerulla A; Gordillo J; Mañosa M; Maisterra S; Cabré E; Garcia-Planella E; Guardiola J; Domènech E
    Dig Liver Dis; 2016 Jun; 48(6):608-12. PubMed ID: 27012443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids.
    Narula N; Marshall JK; Colombel JF; Leontiadis GI; Williams JG; Muqtadir Z; Reinisch W
    Am J Gastroenterol; 2016 Apr; 111(4):477-91. PubMed ID: 26856754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis.
    Maser EA; Deconda D; Lichtiger S; Ullman T; Present DH; Kornbluth A
    Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1112-6. PubMed ID: 18928936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of outcomes of cyclosporine A and infliximab for steroid-refractory acute severe ulcerative colitis.
    Song EM; Oh EH; Hwang SW; Park SH; Yang DH; Byeon JS; Myung SJ; Yang SK; Ye BD
    J Gastroenterol Hepatol; 2021 Sep; 36(9):2463-2470. PubMed ID: 33783045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab for the treatment of acute exacerbations of ulcerative colitis.
    Bryan S; Andronis L; Hyde C; Connock M; Fry-Smith A; Wang D
    Health Technol Assess; 2010 May; 14 Suppl 1():9-15. PubMed ID: 20507798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.